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Abstract
Background: Hepatitis B Virus (HBV) causes acute and chronic liver disease worldwide. HBV has eight geno-
types (A to H) which is the reflection of its genome with their characteristic geographical distribution. Each
genotype could have different pathogenic and therapeutic characteristics. There have been few records on HBV
genotyping in general population from our region. This study aimed to determine hepatitis B genotypes using
sequencing in the general population of Shahrekord, a Southwestern region of Iran.
Methods: A total of 3000 serum samples (cluster sampling method) were enrolled from general population
tested for HBsAg using ELISA. Using appropriate extraction kit, HBV DNA was extracted from HBsAg posi-
tive samples and each was subjected to nested PCR for detection of HBV DNA. Finally, using sequencing, the
samples were used for HBV genotyping. Data were analyzed by SPSS 19 using descriptive statistics, chi square,
and Fisher’s exact test. P-value < 0.05 was considered as the level of significance.
Results: Out of 3000 serum samples, 40 (1.3%) were positive for HBsAg. HBV DNA was detected in 10 out
of 40 (25%) of the samples studied. Genotype D was the predominant HBV type found in all of these 10 HBV
positive samples.
Conclusion: Genotype D is probably the predominant HBV type in our region.
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Introduction
One of the most important health prob-
lems worldwide is hepatitis B virus (HBV)
infection. There are about 400 million per-
sons who are chronically infected by this
virus. Chronic carriers are exposed to the
development of complications arising from
hepatitis B infection, resulting in cirrhosis,
hepatocellular carcinoma, liver failure or
death (1, 2). HBV genotype is one of the
most important factors that influence the
outcome of infection (2, 3). Based on se-
quence divergence in the entire genome,
HBV has been classified into at least 8
genotypes (A–H) that differ >8% from
each other at the nucleotide level (2). Re-
cently, an additional provisional genotype
(I) isolated from Southeast Asians (4) and a
variant were also candidate as the tenth
genotype J (5). Most genotypes can be split
into subgenotypes that differ >4% from
each other, such as HBV-A1 and HBV-A2
(6, 7).
As specific clinical associations with
each genotype become increasingly appar-
ent, HBV genotyping is becoming more
and more important (6). It has been shown
that HBV origin, course of infection, the
severity of the disease (6-8), prognosis and
response to antiviral treatment (7, 9), pat-
terns of serological reactivity and replica-
tion of the virus (7) are mainly genotype
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dependent. Thus, understanding genotype
distribution is important for epidemiologic
characterization of HBV transmission and
to control infection (10).
Geographic distribution of HBV geno-
types regarding regional host population
and endemicity have been widely consid-
ered. Accordingly, HBV/B and HBV/C are
predominant in most parts of Asia, includ-
ing China and Japan (11). Genotypes A, D
and F are prevalent among the five geo-
graphic regions of Brazil. Genotype A was
most prevalent in the United States (12)
while the most common HBV genotype in
Canada was B (13). Genotypes E and F are
confined to Africa and the Americas (14).
HBV/G has a global distribution, and
HBV/H was first revealed in Central Amer-
ica (15). HBV genotypes I and J have been
sporadically reported from Asia and Japan,
respectively (4, 5). Genotype D is also pre-
dominant in the Middle East, including
Iran (16).
Iran located in an intermediate endemic
region for chronic HBV infection with
prevalence rate of 2-8% (17). But, studies
show improvement and prevalence transi-
tion from moderate to low (0.1-2%), due to
vaccination in recent years (18,19). Geno-
type D has been reported as the predomi-
nant genotype in different regions of Iran
(20-27). In our region, although there are
some reports regarding HBV infection
among chronically infected patients (27-
29), there has been no report of HBV geno-
types in general population. Therefore, this
population-based study was aimed to de-
termine HBV genotypes in general popula-
tion of Chaharmahal va Bakhtiari, south-
western Iran.
Methods
Serum samples
This is a descriptive, cross-sectional and
population-based study. The sample popu-
lation consists of rural and urban adults
over 15 years in Chaharmahal va Bakhtiari
province. The sample size was decided to
include 3000 individuals based on statisti-
cal advice, national prevalence of hepatitis
B and the province population, confidence
interval 95%, and relative error 25%. Sam-
pling method was clustering. The clusters
were selected from seven counties of the
province. Totally, 3000 serum samples
were collected from healthy individuals in
normal population.
The inclusion criteria were being 15
years and over and consent to participate.
For taking blood sample, written consent
was obtained from the participants. The
study holds ethics code of 90-2-6 obtained
from the University Ethic Committee. For
HBsAg test, Delaware Kit (Common Mar-
ket) was used.
PCR amplification and detection of HBV
DNA
HBV DNA was extracted from the
HBsAg positive serum samples using an
extraction kit (QIAamp MinElute Virus
Kits, Qiagen, Germany) and subjected to
nested PCR according to the manufactur-
er's instructions using appropriate primers
and positive control provided by kit (Plas-
ma-Serum HBV PCR Detection Kit, Nor-
gen-Canada). Strict measures were adopted
to prevent any contamination. An aliquot
of water was used as negative control.
Samples were considered positive if they
yielded at least two positive results in two
different reactions and were considered
negative when there were two negative re-
sults in two different reactions. To detect
PCR product, the PCR products were ana-
lyzed by electrophoresis through a poly-
acrylamide gel, stained with silver nitrate
and photographed.
HBV sequencing and phylogenetic analy-
sis
Detection of HBV genotypes was per-
formed using sequencing. For sequencing,
the PCR products were purified by Exo
SAP-IT kit (USB Corporation, Ohio, USA)
according to the manufacturer´s instruc-
tion. Sequencing reactions were performed
using 1-5μl purified PCR products, 1μl
BigDye reaction mix (Life Technologies,
Applied Biosystems, Darmstadt, Germany)
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and 0.5μM of the HBV primers, with the
same primers as those used for PCR ampli-
fication of pre-S region. The sequences ob-
tained were compared with published se-
quences from the same genomic region of
8 HBV genotypes available in National
Center for Biotechnology Information
(NCBI) GenBank. Alignment was per-
formed using CLUSTAL W in MEGA 5
software. The phylogenetic tree reconstruc-
tion was carried out using Maximum Com-
posite Likelihood method and MEGA 5
software (Ibis therapeutics Carlsbad,
Carlsbad, CA, USA). This method is a new
genotyping strategy established by Ma et al
in Shenyang, China (30). Data were ana-
lyzed by SPSS 19 using descriptive statis-
tics, chi square, and Fisher’s exact test. P<
0.05 was considered as the level of signifi-
cance.
Results
Out of 3000 serum samples obtained
from healthy individuals, 40 (1.3%) were
positive for HBsAg using ELISA (data not
shown). Ten out of 40 (25%) were positive
for HBV DNA using nested PCR (Figure
1). Demographic characteristics are shown
in Table 1. Chi square and Fisher’s exact
tests revealed no significant difference be-
tween these cases and HBV PCR negative
individuals. The results of sequencing
method showed that genotypes D was the
predominant HBV type found in all of the-
se 10 HBV positive samples (Figs. 2 and
3).
Discussion
This is the first study aimed to evaluate
the distribution of HBV genotypes in the
general population of a Southwestern prov-
ince of Iran, Charmahal va Bakhtiari.
Based on a sequence divergence of 8% or
greater of the entire genome sequences or a
sequence divergence of 4.2% of the S ge-
nome sequences, HBV includes at least
eight genotypes (A-H) (2) with two addi-
tional genotypes recently named I and J
Table1. Demographic characteristics of patients with positive PCR for DNA
Number(%)
Gender Male 5 (50%)
Female 5 (50%)
Age (years) 15-24 1 (10%)
25-34 3 (30%)
35-44 1 (10%)
45-54 2 (20%)
55-64 3 (30%)
Marriage Status married 6 (67%)
single 2 (22%)
widow 1 (11%)
Place of residence Urban 7 (70%)
Rural 3 (30%)
Education Uneducated 1 (10%)
Reading 5 (50%)
Diploma and higher degree 4 (40%)
Vaccination status vaccinated 3 (30%)
Unvaccinated 7 (70%)
Fig. 1. Polyacrylamide gel electrophoresis of the reac-
tion, products of nested PCR and a 50 KB DNA mark-
ers. The second round of amplification products (1-8),
the positive (PC), the negative controls (NC), and mo-
lecular weight marker (M) are shown.
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(4,5,31). There have been a number of re-
ports indicating that most HBV genotypes
are restricted to geographical regions and
associated with a host population around
the world, while others tend to have a
worldwide distribution, or still remain un-
known (3,4). Just as with the genotypes,
the distribution of HBV subgenotypes is
also distinctly geographic (8,9). It has been
suggested that polymorphism, transmis-
sion, mutation and the evolutionary history
of HBV have led to the above outcomes.
Different biological and epidemiologic
behaviors have been attributed to HBV
genotypes (6). Accordingly, they are close-
ly associated with outcome of chronic liver
disease, antiviral response, severity of the
diseases, and disease time course. There-
fore, detection and monitoring of HBV
genotypes are very important to clarify the
pathogenesis, route of infection and viru-
lence of the virus and also in epidemiologic
setting (7-9).
Studies of the distribution of HBV geno-
Fig. 2. Phylogenetic tree constructed with MEGA version5.05 software using the Maximum Likelihood method. Tree
constructed based on 348 bp fragments from 10 HBV amplicon and 8 genotype of HBV obtained from NCBI database.
Genotype of samples is closed with HBV genotype D.
Fig. 3. Phylogenetic tree of 348 bp fragments from 10 HBV isolated in the studied population and 8 standard genotypes
from NCBI database. Tree constructed with DNAstar megalign software. Genotype of samples is closed with HBV geno-
type D.
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types have largely been conducted among
patients with chronic hepatitis B (CHB)
from Iran (26). However, limited studies
carried out to determine genotypes of this
virus in Iranian general population (24).
Accordingly, this is the first study aimed to
understand the overall distribution of HBV
genotypes in general population from a
Southwestern province of Iran.  Our results
identified genotype D as the predominant
genotype in this region. These findings are
concordant with those of the previous stud-
ies conducted in the different regions of the
country where only genotype D was de-
tected in CHB patients (26). Although in
this study, HBV genotype D was detected
in apparently healthy individuals in the
general population, all these results, to-
gether, from different regions, confirm that
genotype D may be the only genotype cir-
culating in this country both in CHB pa-
tients and most probably in the general
population. This result is also consistent
with other published reports from other
countries of the Middle East (16,25) indi-
cating predominance of this genotype in
this region of the world.
It has been suggested that HBV geno-
types have a characteristic geographic dis-
tribution and are closely related to the pro-
cess of human evolution and migration
(16,25). It was found that genotype D is the
predominant HBV genotype in South Asia
and the Middle East including India, Af-
ghanistan and Iran (16) and is dominant in
most parts of Europe (25). Historically, Ar-
ians who firstly colonized to the North of
the Caspian Sea migrated to Iran, India,
and Europe. Therefore, there is a possibil-
ity that the population of this colony has
been infected with genotype D before their
migration and then transmitted the virus to
the following generations after their migra-
tion. Thus, this may be the best explanation
for the prevalence of genotype D in India,
Iran and most parts of the Europe. In coun-
tries with high levels of immigration in the
Europe and North America a variety of
genotypes are being reported (24) which
may depict the impact of immigration on
HBV genotype distribution. Also, the dom-
inancy of this genotype in Iran and the
neighboring countries (25) may indicate
immigration among these countries which
results in circulation of this genotype
among these populations.
The clinical outcomes of the individuals
infected with HBV of genotype D are still
controversial. It has been suggested that it
causes severe chronic liver diseases more
frequently than other genotypes (1,3,16); it
causes high risk of provoking fulminant
hepatitis as well. However, there are some
reports indicating HBV genotype D is re-
lated to acute self-limited hepatitis (9). Fur-
thermore, HBV genotype D has been found
in the majority of asymptomatic carriers
(84.2%) and has not been found in patients
with liver cirrhosis; hepatocellular carci-
noma is lower in genotype D (17). No as-
sociation between HBV of genotype D and
distinct clinical phenotypes has been found
in the Turkish population infected with
HBV (16). Based on our findings, appar-
ently no clinical symptoms were seen in
the infected healthy individuals.  From the-
se results, together, it may be concluded
that the infection caused by genotype D
mainly is mild and/or asymptomatic.
Conclusion
The results of this study may provide
useful regional epidemiologic information.
However, as these results cannot be gener-
alized for all Iranian population, a large
scale, nationwide study should be done to
determine HBV genotypes in general popu-
lation of Iran.
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